• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征衰老小鼠模型中海马 Tau 磷酸化调节改变。

Altered regulation of tau phosphorylation in a mouse model of down syndrome aging.

机构信息

University College London Institute of Neurology, London, UK.

出版信息

Neurobiol Aging. 2012 Apr;33(4):828.e31-44. doi: 10.1016/j.neurobiolaging.2011.06.025. Epub 2011 Aug 16.

DOI:10.1016/j.neurobiolaging.2011.06.025
PMID:21843906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3314962/
Abstract

Down syndrome (DS) results from trisomy of human chromosome 21 (Hsa21) and is associated with an increased risk of Alzheimer's disease (AD). Here, using the unique transchromosomic Tc1 mouse model of DS we investigate the influence of trisomy of Hsa21 on the protein tau, which is hyperphosphorylated in Alzheimer's disease. We show that in old, but not young, Tc1 mice increased phosphorylation of tau occurs at a site suggested to be targeted by the Hsa21 encoded kinase, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A). We show that DYRK1A is upregulated in young and old Tc1 mice, but that young trisomic mice may be protected from accumulating aberrantly phosphorylated tau. We observe that the key tau kinase, glycogen synthase kinase3-β (GSK-3β) is aberrantly phosphorylated at an inhibitory site in the aged Tc1 brain which may reduce total glycogen synthase kinase3-β activity. It is possible that a similar mechanism may also occur in people with DS.

摘要

唐氏综合征(DS)是由于人类 21 号染色体(Hsa21)三体引起的,与阿尔茨海默病(AD)的风险增加有关。在这里,我们使用独特的唐氏综合征跨染色体 Tc1 小鼠模型研究了 Hsa21 三体对蛋白 tau 的影响,tau 在阿尔茨海默病中过度磷酸化。我们表明,在年老的,但不是年轻的,Tc1 小鼠中,tau 的磷酸化在一个被认为是由 Hsa21 编码的激酶双特异性酪氨酸-(Y)-磷酸化调节激酶 1A(DYRK1A)靶向的位点增加。我们表明 DYRK1A 在年轻和年老的 Tc1 小鼠中上调,但年轻的三体小鼠可能免受异常磷酸化 tau 的积累。我们观察到关键的 tau 激酶糖原合酶激酶 3-β(GSK-3β)在年老的 Tc1 大脑中在一个抑制性位点被异常磷酸化,这可能降低总糖原合酶激酶 3-β活性。在患有 DS 的人中,也可能发生类似的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/77f0d674b347/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/cb0295c93fb0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/97530da0a6f1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/966b05960318/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/04aea2a76a07/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/77f0d674b347/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/cb0295c93fb0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/97530da0a6f1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/966b05960318/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/04aea2a76a07/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386f/3314962/77f0d674b347/gr5.jpg

相似文献

1
Altered regulation of tau phosphorylation in a mouse model of down syndrome aging.唐氏综合征衰老小鼠模型中海马 Tau 磷酸化调节改变。
Neurobiol Aging. 2012 Apr;33(4):828.e31-44. doi: 10.1016/j.neurobiolaging.2011.06.025. Epub 2011 Aug 16.
2
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.唐氏综合征小鼠模型中 Dyrk1A 基因剂量的正常化可挽救几种阿尔茨海默病表型。
Neurobiol Dis. 2017 Oct;106:76-88. doi: 10.1016/j.nbd.2017.06.010. Epub 2017 Jun 21.
3
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.Dyrk1A的过表达导致唐氏综合征中的神经原纤维变性。
FASEB J. 2008 Sep;22(9):3224-33. doi: 10.1096/fj.07-104539. Epub 2008 May 28.
4
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.组成型Dyrk1A在阿尔茨海默病、唐氏综合征、皮克病及相关转基因模型中异常表达。
Neurobiol Dis. 2005 Nov;20(2):392-400. doi: 10.1016/j.nbd.2005.03.020.
5
Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.RCAN1 蛋白活性的调节由 Dyrk1A 蛋白介导的磷酸化作用。
J Biol Chem. 2011 Nov 18;286(46):40401-12. doi: 10.1074/jbc.M111.253971. Epub 2011 Sep 30.
6
Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.唐氏综合征中 DYRK1A 过表达与 3 重复 tau 蛋白引起的神经原纤维变性增强数倍之间的联系。
J Neuropathol Exp Neurol. 2011 Jan;70(1):36-50. doi: 10.1097/NEN.0b013e318202bfa1.
7
The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.过表达的DYRK1A蛋白在唐氏综合征神经原纤维变性早期发作中的作用。
Acta Neuropathol. 2008 Oct;116(4):391-407. doi: 10.1007/s00401-008-0419-6. Epub 2008 Aug 12.
8
Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.蛋白磷酸酶 PPM1B 通过去磷酸化 pS258 抑制 DYRK1A 激酶,减少毒性 tau 聚集。
J Biol Chem. 2021 Jan-Jun;296:100245. doi: 10.1074/jbc.RA120.015574. Epub 2021 Jan 8.
9
microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing.miRNAs 的表达与唐氏综合征小鼠模型海马 APP、DYRK1A、过度磷酸化 Tau 和 BDNF 水平随年龄增长的相关性。
Neurosci Lett. 2020 Jan 1;714:134541. doi: 10.1016/j.neulet.2019.134541. Epub 2019 Oct 9.
10
Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.亮丙西丁L41,一种优先作用于双重特异性酪氨酸磷酸化调节激酶1A(DYRK1A)的双重特异性酪氨酸磷酸化调节激酶/细胞周期蛋白依赖性激酶(DYRKs/CLKs)抑制剂,可预防小鼠因给予淀粉样β蛋白25-35寡聚肽而引起的记忆障碍和神经毒性。
Eur Neuropsychopharmacol. 2015 Nov;25(11):2170-82. doi: 10.1016/j.euroneuro.2015.03.018. Epub 2015 Apr 10.

引用本文的文献

1
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.与 APP 双突变和唐氏综合征家族性阿尔茨海默病相关的脑淀粉样血管病的淀粉样-β肽特征。
Acta Neuropathol. 2024 Jul 18;148(1):8. doi: 10.1007/s00401-024-02756-4.
2
Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behavior.在Ts65Dn小鼠中模拟阿尔茨海默病相关表型:年龄对Aβ、Tau、pTau、NfL及行为的影响
Front Neurosci. 2023 Jun 28;17:1202208. doi: 10.3389/fnins.2023.1202208. eCollection 2023.
3
Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality.

本文引用的文献

1
GSK3 signalling in neural development.GSK3 信号在神经发育中的作用。
Nat Rev Neurosci. 2010 Aug;11(8):539-51. doi: 10.1038/nrn2870.
2
Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse.唐氏综合征样心脏发育缺陷在转染色体 Tc1 小鼠胚胎中。
Cardiovasc Res. 2010 Nov 1;88(2):287-95. doi: 10.1093/cvr/cvq193. Epub 2010 Jun 16.
3
Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.唐氏综合征 Tc1 小鼠模型中肿瘤血管生成减少。
通过磷酸化靶向嵌合体(PhosTACs)对tau蛋白进行靶向去磷酸化作为一种治疗方式。
J Am Chem Soc. 2023 Feb 8. doi: 10.1021/jacs.2c11706.
4
The accumulation of copper in the brain of Down syndrome promotes oxidative stress: possible mechanism underlying cognitive impairment.唐氏综合征患者大脑中铜的积累会促进氧化应激:认知障碍潜在的机制。
J Clin Biochem Nutr. 2022 Jul;71(1):16-21. doi: 10.3164/jcbn.21-155. Epub 2022 Feb 15.
5
Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21.唐氏综合征 21 号染色体三体性对 APP 与淀粉样-β 生物学调节的遗传定位。
J Neurosci. 2022 Aug 17;42(33):6453-6468. doi: 10.1523/JNEUROSCI.0521-22.2022. Epub 2022 Jul 14.
6
Rodent Modeling of Alzheimer's Disease in Down Syndrome: and Approaches.唐氏综合征中阿尔茨海默病的啮齿动物模型及方法
Front Neurosci. 2022 Jun 7;16:909669. doi: 10.3389/fnins.2022.909669. eCollection 2022.
7
Cell models for Down syndrome-Alzheimer's disease research.用于唐氏综合征-阿尔茨海默病研究的细胞模型。
Neuronal Signal. 2022 Apr 8;6(1):NS20210054. doi: 10.1042/NS20210054. eCollection 2022 Apr.
8
The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.Cstb 基因重复对 APP/淀粉样β 病理学和组织蛋白酶 B 活性的影响。
PLoS One. 2021 Jul 22;16(7):e0242236. doi: 10.1371/journal.pone.0242236. eCollection 2021.
9
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.针对阿尔茨海默病和 tau 病的磷酸化 tau 靶向小分子 PROTACs。
Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166162. doi: 10.1016/j.bbadis.2021.166162. Epub 2021 Apr 30.
10
Substantially thinner internal granular layer and reduced molecular layer surface in the cerebellar cortex of the Tc1 mouse model of down syndrome - a comprehensive morphometric analysis with active staining contrast-enhanced MRI.唐氏综合征 Tc1 小鼠模型小脑皮质内颗粒层明显变薄,分子层表面减少——主动染色对比增强 MRI 的综合形态计量分析。
Neuroimage. 2020 Dec;223:117271. doi: 10.1016/j.neuroimage.2020.117271. Epub 2020 Aug 22.
Nature. 2010 Jun 10;465(7299):813-7. doi: 10.1038/nature09106.
4
Tau hyperphosphorylation is associated with memory impairment after exposure to 1.5% isoflurane without temperature maintenance in rats.tau 过度磷酸化与未维持体温的大鼠接触 1.5%异氟醚后记忆损伤有关。
Eur J Anaesthesiol. 2010 Sep;27(9):835-41. doi: 10.1097/EJA.0b013e32833a6561.
5
Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.tau 蛋白缺失会引起阿尔茨海默病小鼠模型中的轴突变性。
Neuroscience. 2010 Aug 11;169(1):516-31. doi: 10.1016/j.neuroscience.2010.04.037. Epub 2010 Apr 29.
6
Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.唐氏综合征 Tc1 小鼠模型中的造血功能紊乱。
Blood. 2010 Apr 8;115(14):2928-37. doi: 10.1182/blood-2009-06-227629. Epub 2010 Feb 12.
7
DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping.DYRK1A 和糖原合酶激酶 3β,一种双激酶机制,指导 CRY2 的蛋白酶体降解以进行生物钟计时。
Mol Cell Biol. 2010 Apr;30(7):1757-68. doi: 10.1128/MCB.01047-09. Epub 2010 Feb 1.
8
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.高内涵 siRNA 筛选激酶组发现与阿尔茨海默病相关的 tau 过度磷酸化有关的激酶。
BMC Genomics. 2010 Jan 12;11:25. doi: 10.1186/1471-2164-11-25.
9
Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain.乙醇诱导的发育中鼠脑神经退行性变中的 Tau 磷酸化和裂解。
Neurochem Res. 2010 Apr;35(4):651-9. doi: 10.1007/s11064-009-0116-4. Epub 2010 Jan 5.
10
GSK3: a multifaceted kinase in Wnt signaling.GSK3:Wnt 信号通路中的一个多面激酶。
Trends Biochem Sci. 2010 Mar;35(3):161-8. doi: 10.1016/j.tibs.2009.10.002. Epub 2009 Oct 31.